30 November 2018
The United Kingdom of Green Britain
As medicinal cannabis hits the U.K., CTA’s Harry Parsons takes a look at the ground-breaking reform taking place and how it could impact clinical research
Trending menu:
Comment
-
20 November 2018
Approaching Clinical Trials Where the Air Hurts Your Face
Colin Enz, CSM & Russell Brierley, Lupin Research Inc, outline the key challenges involved in handling cryogenic pharmaceutical products
-
19 November 2018
Clinical Evaluation for Software as a Medical Device
Monir El Azzouzi, Quality Operation Manager, Johnson & Johnson, explains what is needed for a Software as a Medical Device
-
16 November 2018
How Can Blockchain Disrupt the Pharma Industry?
CTA Editor Henry Kerali explores what impact blockchain could have on clinical research
-
14 November 2018
The Ongoing Fight Against Diabetes
On World Diabetes Day, CTA’s Harry Parsons delves in to the disease, looking at the impact it has on families
-
14 November 2018
How to Conduct a Diabetes Trial – Lessons Learned
Jacqueline Mardell, Ascendis Pharma, recounts experiences from a multinational type 2 diabetes trial and draws conclusions
-
9 November 2018
Poor Communication Can Cost You – REALLY Cost You
Daria Wicks, Director, Clinical Operations, Vericel Corporation, emphasizes the importance of clear communication within an organization
-
2 November 2018
Global Standards for Identification: Untapped Opportunities in the Clinical Trial Supply Chain
Jesper Franke, Head of Healthcare, GS1 Denmark, explains how the industry can best improve supply chain processes by adopting industry standards
-
1 November 2018
Virtual Clinical Trials: Are Site-less Trials the Future?
CTA’s Anne-Marie Mongan unpacks the tangible benefits of going virtual
-
29 October 2018
Patient Recruitment and Retention Considerations for Clinical Trials in Latin America
Wagner Souza, Clinical Research Manager, AstraZeneca Brazil, shares his thoughts about the challenges of patient recruitment and retention in Latin America